SCHEMBL29066652

SCHEMBL29066652

Cc1cc(NC(=O)C2(C(=O)O)CC2)no1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.58
MAPT P10636 2/20 0.53
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ALDH1A1 P00352 3/20 0.50
EGFR P00533 1/20 0.50
GAA P10253 1/20 0.50
POLB P06746 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
EPHX2 P34913 1/20 0.48
GAPDH P04406 1/20 0.48
TSHR P16473 1/20 0.48
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30421543 0.86 SMN1; SMN2 (0.57) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL29577697 0.85 RAB9A (0.57) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL25567547 0.81 HPGD (0.61) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL1888991 0.77 MAPT (0.69) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL1430419 0.72 MAPT (0.67) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL22462220 0.71 MAPT (0.61) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL5803752 0.71 MAPT (0.65) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL172042 0.71 MAPT (0.65) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL171882 0.71 MAPT (0.70) SMN1; SMN2MAPTRAB9ANPC1MEN1
SCHEMBL15144367 0.70 LMNA (0.52) SMN1; SMN2MAPTRAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116284043-B Tricyclic compound and medical application thereof 中国科学院上海药物研究所 2024-06-11 CN disclosed
CN-116284043-A Tricyclic compound and medical application thereof 中国科学院上海药物研究所 2023-06-23 CN disclosed